Depleção de volume em adultos

Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 Nov;47(11):1181-247.Texto completo  Resumo

National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. May 2017 [internet publication].Texto completo

1. Mange K, Matsuura D, Cizman B, et al. Language guiding therapy: the case of dehydration versus volume depletion. Ann Intern Med. 1997 Nov 1;127(9):848-53. Resumo

2. McGee S, Abernethy WB 3rd, Simel DL. The rational clinical examination: is this patient hypovolemic? JAMA. 1999 Mar 17;281(11):1022-9. Resumo

3. Batlle D, Chen S, Haque S. Physiological principles in the clinical evaluation of electrolyte, water, and acid-base disorders. In: Alpern RJ, Caplan MJ, Moe OW, eds. Seldin and Giebisch's the kidney: physiology and pathophysiology. 5th ed. San Diego, CA: Academic Press; 2012:2477-512.

4. Di Somma S, Gori, CS, Grandi T, et al. Fluid assessment and management at the emergency department. Fluid overload diagnosis and management. Contrib Nephrol. 2010;164:227-36. Resumo

5. Rose BD, Post TW. Hypovolemic states. In: Clinical physiology of acid-base and electrolyte disorders. 5th ed. New York, NY: McGraw-Hill; 2001:415-46.

6. Bhave G, Neilson EG. Volume depletion versus dehydration: how understanding the difference can guide therapy. Am J Kidney Dis. 2011 Aug;58(2):302-9.Texto completo  Resumo

7. Alam NH, Majumder RM, Fuchs GJ. Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: a randomised double-blind clinical trial. Lancet. 1999 Jul 24;354(9175):296-9. Resumo

8. Uribarri J, Oh MS, Carroll HJ. Salt-losing nephropathy: clinical presentation and mechanisms. Am J Nephrol. 1983 Jul-Aug;3(4):193-8. Resumo

9. Portilla D, Andreoli TE. Disorders of extracellular volume. In: Johnson RJ, Feehally J, eds. Comprehensive clinical nephrology. London: Mosby International; 2007:77-91.

10. Better OS. Impaired fluid and electrolyte balance in hot climates. Kidney Int Suppl. 1987 Aug;21:S97-101. Resumo

11. Antman EM. Hemodynamic disturbances. In: Libby P, Bonow R, Mann D, et al, eds. Braunwald's heart disease: a textbook of cardiac medicine. 8th ed. Philadelphia, PA: Saunders; 2008.

12. Powell-Tuck J, Gosling P, Lobo DN, et al. British consensus guidelines on intravenous fluid therapy for adult surgical patients. February 2018 [internet publication].Texto completo

13. Brienza N, Giglio MT, Marucci M, et al. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med. 2009 Jun;37(6):2079-90. Resumo

14. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 Nov;47(11):1181-247.Texto completo  Resumo

15. Schuetz P, Birkhahn R, Sherwin R, et al. Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin MOnitoring SEpsis (MOSES) Study. Crit Care Med. 2017 May;45(5):781-89.Texto completo  Resumo

16. Kip MM, Kusters R, IJzerman MJ, et al. A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis. J Med Econ. 2015;18(11):944-53.Texto completo  Resumo

17. Colucci LA, Corapi KM, Li M, et al. Fluid assessment in dialysis patients by point-of-care magnetic relaxometry. Sci Transl Med. 2019 Jul 24;11(502). Resumo

18. Shehabi Y, Sterba M, Garrett PM; ProGUARD Study Investigators; ANZICS Clinical Trials Group. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial. Am J Respir Crit Care Med. 2014 Nov 15;190(10):1102-10.Texto completo  Resumo

19. Andriolo BN, Andriolo RB, Salomão R, et al. Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev. 2017 Jan 18;1(1):CD010959.Texto completo  Resumo

20. Lam SW, Bauer SR, Fowler R, et al. Systematic review and meta-analysis of procalcitonin-guidance versus usual care for antimicrobial management in critically Ill patients: focus on subgroups based on antibiotic initiation, cessation, or mixed strategies. Crit Care Med. 2018 May;46(5):684-90. Resumo

21. Phua J, Koay ES, Lee KH. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock. 2008 Mar;29(3):328-33.Texto completo  Resumo

22. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 2008 Mar;36(3):941-52. Resumo

23. Hooper L, Bunn DK, Abdelhamid A, et al. Water-loss (intracellular) dehydration assessed using urinary tests: how well do they work? Diagnostic accuracy in older people. Am J Clin Nutr. 2016 Jul;104(1):121-31.Texto completo  Resumo

24. Fortes MB, Owen JA, Raymond-Barker P, et al. Is this elderly patient dehydrated? Diagnostic accuracy of hydration assessment using physical signs, urine, and saliva markers. J Am Med Dir Assoc. 2015 Mar;16(3):221-8. Resumo

25. Balk RA. Severe sepsis and septic shock: definitions, epidemiology, and clinical manifestations. Crit Care Clin. 2000 Apr;16(2):179-92. Resumo

26. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol. 2002 Sep;110(3):341-8.Texto completo  Resumo

27. Kramer GC, Kinsky MP, Prough DS, et al. Closed-loop control of fluid therapy for treatment of hypovolemia. J Trauma. 2008 Apr;64(4 Suppl):S333-41. Resumo

28. Roberts I, Blackhall K, Alderson P, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2011 Nov 9;(11):CD001208.Texto completo  Resumo

29. Lewis SR, Pritchard MW, Evans DJ, et al. Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev. 2018 Aug 3;(8):CD000567.Texto completo  Resumo

30. Semler MW, Self WH, Wanderer JP, et al. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018 Mar 1;378(9):829-39.Texto completo  Resumo

31. Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013 Feb 20;309(7):678-88.Texto completo  Resumo

32. European Medicines Agency. PRAC recommends suspending hydroxyethyl-starch solutions for infusion from the market. Feb 2022 [internet publication].Texto completo

33. Food and Drug Administration. Labeling changes on mortality, kidney injury, and excess bleeding with hydroxyethyl starch products. Jul 2021 [internet publication].Texto completo

34. Kraut JA, Kurtz I. Treatment of acute non-anion gap metabolic acidosis. Clin Kidney J. 2015 Feb;8(1):93-9.Texto completo  Resumo

35. Jung B, Martinez M, Claessens YE, et al. Diagnosis and management of metabolic acidosis: guidelines from a French expert panel. Ann Intensive Care. 2019 Aug 15;9(1):92.Texto completo  Resumo

36. Kellum JA. Acute kidney injury. Crit Care Med. 2008 Apr;36(4 Suppl):S141-5. Resumo

37. National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. May 2017 [internet publication].Texto completo

38. Duggan JM. Personal view: crystalloid transfusion in acute gastrointestinal haemorrhage: is it beneficial? An historical perspective. Aliment Pharmacol Ther. 2006 Aug 1;24(3):493-6. Resumo

39. Hambly PR, Dutton RP. Excess mortality associated with the use of rapid infusion at a level 1 trauma center. Resuscitation. 1996 Apr;31(2):127-33. Resumo

40. Antonelli M, Levy M, Andrews PJ, et al. Hemodynamic monitoring in shock and implications for management: international consensus conference, Paris, France, 27-28 April 2006. Intensive Care Med. 2007 Apr;33(4):575-90. Resumo

41. Cappell MS, Friedel D. Initial management of acute upper gastrointestinal bleeding: from initial evaluation up to gastrointestinal endoscopy. Med Clin North Am. 2008 May;92(3):491-509. Resumo

42. Ipaktchi K, Arbabi S. Advances in burn critical care. Crit Care Med. 2006 Sep;34(9 Suppl):S239-44. Resumo

43. Charache S, Ness PM. Transfusion therapy. In: Stobo JD, Hellmann DB, Ladenson PW, et al, eds. The principles and practice of medicine. 23rd ed. New York, NY: McGraw-Hill Professional; 1996:761-8.

44. Hellstern P, Muntean W, Schramm W, et al. Practical guidelines for the clinical use of plasma. Thromb Res. 2002 Oct 31;107 Suppl 1:S53-7. Resumo

45. European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide. July 2013 [internet publication].Texto completo

46. Cooper DJ, Walley KR, Wiggs BR, et al. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: a prospective, controlled clinical study. Ann Intern Med. 1990 Apr 1;112(7):492-8. Resumo

47. Bagshaw SM, Townsend DR, McDermid RC. Disorders of sodium and water balance in hospitalized patients. Can J Anaesth. 2009 Feb;56(2):151-67. Resumo

48. Kristensen AK, Holler JG, Hallas J, et al. Is shock index a valid predictor of mortality in emergency department patients with hypertension, diabetes, high age, or receipt of β- or calcium channel blockers? Ann Emerg Med. 2016 Jan;67(1):106-13. Resumo